rs745406424
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_198576.4(AGRN):c.3974C>G(p.Ala1325Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000583 in 1,543,466 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A1325A) has been classified as Likely benign.
Frequency
Consequence
NM_198576.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 8Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- presynaptic congenital myasthenic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- postsynaptic congenital myasthenic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AGRN | ENST00000379370.7 | c.3974C>G | p.Ala1325Gly | missense_variant | Exon 23 of 36 | 1 | NM_198576.4 | ENSP00000368678.2 | ||
| AGRN | ENST00000651234.1 | c.3659C>G | p.Ala1220Gly | missense_variant | Exon 22 of 38 | ENSP00000499046.1 | ||||
| AGRN | ENST00000652369.2 | c.3659C>G | p.Ala1220Gly | missense_variant | Exon 22 of 35 | ENSP00000498543.1 | ||||
| AGRN | ENST00000620552.4 | c.3560C>G | p.Ala1187Gly | missense_variant | Exon 23 of 39 | 5 | ENSP00000484607.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152174Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 139902 AF XY: 0.00
GnomAD4 exome AF: 0.00000575 AC: 8AN: 1391292Hom.: 0 Cov.: 35 AF XY: 0.00000729 AC XY: 5AN XY: 685494 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74350 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.3974C>G (p.A1325G) alteration is located in exon 23 (coding exon 23) of the AGRN gene. This alteration results from a C to G substitution at nucleotide position 3974, causing the alanine (A) at amino acid position 1325 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Congenital myasthenic syndrome 8 Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 1325 of the AGRN protein (p.Ala1325Gly). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with AGRN-related conditions. ClinVar contains an entry for this variant (Variation ID: 541171). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at